FDA action can and will eventually get the market’s attention, not only damaging the erstwhile credibility of the firm but its enterprise value as well.
J&J may have lost this battle, but I’ll bet they’ll win the war. They stayed cool and retreated when they knew that prices were heading into Silly Land.